ArticleInternational journal of hematology2023

Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11.

Shinsuke Iida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.